|
|
||||||||
Ann Thorac Surg 2005;79:1669-1675
© 2005 The Society of Thoracic Surgeons
Department of Adult and Pediatric Cardiac Surgery, La Timone University Hospital, Marseille, France
Accepted for publication October 22, 2004.
* Address reprint requests to Dr Metras, Department of Thoracic and Cardiac Surgery, "La Timone" Children's Hospital, 264 Rue Saint Pierre, 13385, Marseille, France (E-mail: dmetras{at}mail.ap-hm.fr).
BACKGROUND: The purpose of this study was to find homograft-related factors that might be associated with the development of stenosis after the Ross procedure, as well as to identify the natural dynamics of stenosis and find echographic cutoff values after one year of follow-up that might predict such an outcome.
METHODS: We followed up 71 patients (mean age, 24.27 ± 16.57 years) who had such a procedure prospectively by transthoracic echocardiography, between 1993 and 2002. Follow-up was 55.26 ± 29.63 months and was 90.14% complete. Homografts were harvested from heart-beating donors or cardiac transplant recipients. Allograft stenosis was analyzed and risk factors were identified by univariate, multivariate, and survival analysis methods. Stenosis was defined as a mean gradient greater than or equal to 20 mm Hg.
RESULTS: There were two reoperations and 21 homografts were stenotic at the last follow-up, ten of which were already so at one year after the procedure. Cox regression analysis revealed a transhomograft gradient greater than 9 mm Hg at 1 year after the procedure (hazard ratio [HR] = 10.04) and homograft size (HR = 0.75) as independent predictors for stenosis. Stenosis-free survival was 85.94 ± 4.35%, 75.51 ± 5.55%, and 68.56 ± 6.34 after 1, 3, and 5 years, respectively. A cutoff value of 9 mm Hg at 1 year of follow-up could predict different stenosis-free survival rates.
CONCLUSIONS: Homograft size is the most important homograft-related factor for stenosis. Most of the increase in transhomograft gradient occurs in the first 24 months. A gradient of 9 mm Hg or more after 1 year predicts the late occurrence of stenosis.
This article has been cited by other articles:
![]() |
J. O. Bohm, W. Hemmer, J.-G. Rein, A. Horke, D. Roser, G. Blumenstock, and C. A. Botha A single-institution experience with the ross operation over 11 years. Ann. Thorac. Surg., February 1, 2009; 87(2): 514 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Brown, M. Ruzmetov, M. D. Rodefeld, and M. W. Turrentine Right Ventricular Outflow Tract Reconstruction in Ross Patients: Does the Homograft Fare Better? Ann. Thorac. Surg., November 1, 2008; 86(5): 1607 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Grotenhuis, A. de Roos, J. Ottenkamp, P. H. Schoof, H. W. Vliegen, and L. J. M. Kroft MR Imaging of Right Ventricular Function after the Ross Procedure for Aortic Valve Replacement: Initial Experience Radiology, December 4, 2007; (2007) 2462070198. [Abstract] [Full Text] |
||||
![]() |
D. Boethig, H. Goerler, M. Westhoff-Bleck, M. Ono, A. Daiber, A. Haverich, and T. Breymann Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 133 - 142. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |